Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D201/00—Preparation, separation, purification or stabilisation of unsubstituted lactams
  • C07D201/16—Separation or purification
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
  • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
  • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D223/08—Oxygen atoms
  • C07D223/10—Oxygen atoms attached in position 2

Definitions

• the invention relates to a process for purifying caprolactam, which process involves distilling alkaline caprolactam product at reduced pressure.
• caprolactam generally involves the preparation of caprolactam product, e.g. by Beckmann rearrangement, followed by purification of the caprolactam product to obtain polymerizable grade caprolactam product.
• the purification can include distillation of the caprolactam product at reduced pressure in the presence of a base, e.g. alkali hydroxide or an alkali amino caproate. Large ranges are mentioned for the amount of added base.
• DD-A-202870 describes a process in which caprolactam product is purified by distillation under reduced pressure after addition of 0.05 to 1.0% of the alkali salt of caproic acid to the caprolactam product to be purified.
• 3,839,324 describes a process in which caprolactam is subjected to an alkaline distillation in vacuo, wherein sodium hydroxide is present as 0.05-0.5 percent by weight.
• U.S. Pat. No. 5,496,941 describes a process wherein caprolactam is distilled in the presence of a base, the amount of added base as a rule being chosen from 0.05 to 0.9 mol. % based on caprolactam.
• U.S. Pat. No. 4,457,807 describes a process in which untreated caprolactam containing 0.2 mg of solid NaOH per gram of caprolactam (5 mmol NaOH per kg of caprolactam) is supplied to a rectification column wherein rectification is effected under reduced pressure.
• the quality of the purified caprolactam is influenced by the alkalinity of the caprolactam product to be distilled.
• the PAN number is found to decrease when the alkalinity of the alkaline caprolactam product is decreased to below 5 meq. per kg of caprolactam.
• the occurrence of undesired fluctuation in quality e.g. resulting from the oxidation of caprolactam during distillation, is found to decrease when the alkalinity is increased to above 0 meq. per kg of caprolactam.
• the invention provides a process for purifying caprolactam, which process involves distilling alkaline caprolactam product at reduced pressure, said alkaline caprolactam product comprising (i) caprolactam, (ii) impurities, and (iii) one or more bases selected from the group consisting of alkali hydroxide and alkali amino caproate, characterized in that the alkalinity of the alkaline caprolactam product is less than 5 meq. (5 milli equivalent) per kg of caprolactam.
• alkalinity v * t a * 0.15 * 1000
• the process according to the invention results in purified caprolactam having a high quality, in particular a low PAN number (as determined in accordance with ISO DIS 8660-Plastics-Determination of permanganate index of caprolactame-Spectometric method, revision of first edition (ISO 8660; 1988)). Moreover a low value for the extinction (as determined in accordance with ISO 7059—caprolactam for industrial use—Determination of absorbance at a wavelength of 290 nm) is obtained.
• the alkalinity of the alkaline caprolactam product is lower than 4.5 meq. per kg of alkaline caprolactam product, more preferably lower than 4.0 meq. per kg, in particular lower than 3.0 meq. per kg, more in particular lower than 2.0 meq. per kg. This further decreases the PAN number.
• the alkalinity of the alkaline caprolactam product is higher than 0.05 meq. per kg of alkaline caprolactam product, more preferably higher than 0.10 meq. per kg, in particular higher than 0.15 meq. per kg. Increasing the alkalinity to above these values improves the stability, i.e. the sensitivity to occurrence of undesired fluctuations in quality.
• the values mentioned for the alkalinity and concentrations in the alkaline caprolactam product refer to the values of the alkaline caprolactam product to be distilled. viz. when the alkaline caprolactam product is fed to a distillation zone, i.e. the zone in which the distillation is effected, the mentioned values for alkalinity and other concentrations in the alkaline caprolactam product refer to the values in the alkaline caprolactam product entering the distillation zone.
• the alkaline caprolactam product comprises caprolactam.
• the alkaline caprolactam product comprises 95 to 99.9 wt. % of caprolactam, in particular at least 97 wt. % of caprolactam, more in particular at least 98 wt. % of caprolactam (relative to the weight of alkaline caprolactam product).
• the impurities may be any organic impurities, e.g. low-boiling organic impurities (having a lower boiling point than caprolactam) and/or high-boiling organic impurities (having a higher boiling point than caprolactam).
• organic impurities e.g. low-boiling organic impurities (having a lower boiling point than caprolactam) and/or high-boiling organic impurities (having a higher boiling point than caprolactam).
• the alkaline caprolactam product may include water.
• the alkaline caprolactam product comprises less than 5 wt. %, more preferably less than 3 wt. %, in particular less than 2 wt. %, more in particular less than 1 wt. % (relative to the weight of alkaline caprolactam product).
• a lower amount of water has the advantage that a reduced pressure is easier to create and maintain during distilling.
• the alkaline caprolactam product comprises one or more bases selected from the group consisting of alkali hydroxide and alkali amino caproate.
• the one or more bases are selected from the group consisting of sodium hydroxide, sodium amino caproate, potassium hydroxide, and potassium amino caproate, more preferably selected from the group consisting of sodium hydroxide and sodium amino caproate.
• at least 75 mol. %, more preferably at least 85 mol. %, in particular at least 95 mol. %, more in particular substantially all of said one or more bases is alkali amino caproate.
• Increasing the relative amounts of alkali amino caproate has the advantage that the occurrence of polymerization during the distillation is lessened. The formation of oligomers and polymers is disadvantageous since it may result fouling of the distillation equipment. Moreover caprolactam is lost. The above percentages are given relative to the total molar quantity of said one or more bases.
• the process according to the invention is preferably a process for the purification of caprolactam product, said caprolactam product comprising (i) caprolactam and (ii) impurities, wherein said process comprises adding one or more of the bases to said caprolactam product to yield the alkaline caprolactam product.
• the alkali hydroxide is added as an aqueous solution of alkali hydroxide.
• the caprolactam product comprises 15 to 99.9 wt. % of caprolactam, in particular at least 50 wt. % of caprolactam, more in particular at least 75 wt. % of caprolactam.
• the caprolactam product is aqueous caprolactam product comprising water.
• the sum quantity of water and caprolactam and water in the caprolactam product is preferably at least 95 wt. %, in particular at least 97 wt. %, more in particular at least 98 wt. %. These percentages are given relative to the weight of the caprolactam product.
• the caprolactam product has an acidity of between 0 and 5 meq.
• the alkaline caprolactam product can be prepared by adding very small amounts of said one ore more bases. This results in purified caprolactam having a good quality, as expressed by the PAN number, and a good stability.
• the caprolactam product is neutral or has an alkalinity of between 0 and 5 meq. per kg of caprolactam.
• the process comprises adding between 0.05 and 10 mmol of the one or more bases per kg caprolactam, preferably between 0.05 and 5.0 mmol per kg, more preferably between 0.10 and 4.5 mmol per kg, in particular between 0.15 and 3.0 mmol per kg, more in particular between 0.20 and 2.0, most preferably less than 1.0 mmol per kg caprolactam.
• the amount of added base is decreased when the caprolactam product is less acidic/more alkaline.
• the alkaline caprolactam product is directly obtained after addition of the one or more bases, and the alkaline caprolactam product may be distilled without further steps prior to said distilling.
• alkaline product obtained following the addition is subjected to one or more purification steps, e.g. to a step in which water is separated from the alkaline product, to obtain the alkaline caprolactam product to be distilled.
• the process involves adding alkali hydroxide to the caprolactam product, yielding an alkaline product, and reacting at least part of said alkali hydroxide in the alkaline product to form alkali amino caproate prior to the distilling.
• the alkali hydroxide is preferably added to caprolactam product comprising at least 3 wt. % water, more preferably at least 5 wt. % of water (relative to the total weight of the caprolactam product).
• Alkali hydroxide may advantageously be converted to form alkali amino caproate during a water separation step.
• the process according to the invention may be a batch process or a continuous process.
• the process is a continuous process.
• the caprolactam product to which said one or more bases may be added may be obtained in various ways, e.g. by Beckmann rearrangement.
• a Beckmann rearrangement of cyclohexanone oxime may be effected in the presence of sulphuric acid or oleum, resulting in a Beckmann rearrangement mixture.
• a base, preferably ammonia, may be added to the Beckmann rearrangement mixture, resulting in a neutralized Beckmann rearrangent mixture.
• the preparation of the caprolactam product includes, (a) recovering from a neutralized Beckmann rearrangement mixture, by extraction with an organic solvent, an organic product comprising the organic solvent and caprolactam, (b) recovering from said organic product, by extraction with water or by evaporation of the organic solvent in the presence of water, an aqueous caprolactam product.
• the aqueous caprolactam product is preferably hydrogenated in the presence of a hydrogenation catalyst.
• the organic product is preferably washed with water or with an alkaline aqueous solution prior to said evaporation.
• the aqueous caprolactam product is preferably subjected to an ion exchanger prior to hydrogenation.
• said one or more bases are added to the aqueous caprolactam product after a hydrogenation step.
• the distillation may be carried out in any suitable distillation zone, for instance a distillation column.
• the distillation is effected at reduced pressure.
• the distillation is effected at a pressure of less than 50 kPa, more preferably less than 20 kPa, in particular less than 10 kPa.
• the temperature is between 100 and 200° C., more preferably between 110 and 180° C. These temperatures refer to the temperature in the bottom of the distillation column in which the distillation is effected.
• the distilling includes separating low-boiling organic impurities (having a lower boiling point than caprolactam) from the alkaline caprolactam product and/or separating organic high-boiling impurities (having a higher boiling point than caprolactam) from the alkaline caprolactam product.
• the distilling includes, in a first step, separating out as a top product low-boiling impurities from the alkaline caprolactam product while leaving alkaline caprolactam product containing high-boiling impurities as a bottom product, and, in a second step, separating out high-boiling impurities from the bottom product, and recovering purified caprolactam as a top product.
• the caprolactam is ⁇ -caprolactam
• a stream of caprolactam product was continuously produced by Beckmann rearrangement of cyclohexanone oxime in the presence of oleum, neutralizing the Beckmann rearrangement mixture with ammonia, separating caprolactam from the neutralized Beckmann rearrangement by extraction techniques. Said stream was subjected to a series of purification steps including purification with an ion exchanger, hydrogenation and a first dewatering. The resulting stream of caprolactam product contained about 85 wt. % caprolactam, about 15 wt.
• alkaline caprolactam product was obtained containing about 0.5 wt. % water.
• alkaline caprolactam product at least 90% added base appeared to have been reacted to form sodium amino caproate.
• low-boiling impurities and water were separated in a distillation column, at (bottom) temperature of 175° C., and a pressure of 5.2 kPa, the residence time being several minutes.
• high-boiling impurities were separated in a distillation column at a (bottom) temperature of 133° C., a pressure of 1.2 kPa, the residence time being 1 hour.
• the specifications of the resulting purified caprolactam are indicated in table 1.
• Example I was repeated with the difference that different amounts of NaOH were added, resulting in different values for the alkalinity of the feed of the first distillation step (distillation at 175° C.).
• the specifications of the caprolactam obtained after distillation are indicated in table 1.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Other In-Based Heterocyclic Compounds (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
• Separation, Recovery Or Treatment Of Waste Materials Containing Plastics (AREA)

Applications Claiming Priority (7)

Publications (1)

Family

ID=27224307

Family Applications (2)

Family Applications Before (1)

Country Status (18)

Cited By (2)

Families Citing this family (2)

Citations (9)

Family Cites Families (7)

• 2002
  • 2002-08-23 JP JP2003523214A patent/JP4368197B2/ja not_active Expired - Fee Related
  • 2002-08-23 EP EP02753297.7A patent/EP1423369B1/en not_active Expired - Lifetime
  • 2002-08-23 CN CNB028208226A patent/CN1284774C/zh not_active Expired - Lifetime
  • 2002-08-23 KR KR1020047002816A patent/KR100907146B1/ko not_active Expired - Lifetime
  • 2002-08-23 DE DE60239205T patent/DE60239205D1/de not_active Expired - Lifetime
  • 2002-08-23 PL PL02367897A patent/PL367897A1/xx unknown
  • 2002-08-23 EA EA200400359A patent/EA006481B1/ru not_active IP Right Cessation
  • 2002-08-23 AT AT02753298T patent/ATE498611T1/de not_active IP Right Cessation
  • 2002-08-23 WO PCT/NL2002/000558 patent/WO2003018562A1/en not_active Ceased
  • 2002-08-23 CN CNB028166736A patent/CN1252050C/zh not_active Expired - Lifetime
  • 2002-08-23 ES ES02753297T patent/ES2429363T3/es not_active Expired - Lifetime
  • 2002-08-23 WO PCT/NL2002/000559 patent/WO2003018550A1/en not_active Ceased
  • 2002-08-23 BR BR0212067-4A patent/BR0212067A/pt not_active IP Right Cessation
  • 2002-08-23 BR BR0212118-2A patent/BR0212118A/pt not_active IP Right Cessation
  • 2002-08-23 KR KR20047002830A patent/KR20040031007A/ko not_active Ceased
  • 2002-08-23 US US10/486,727 patent/US7615137B2/en not_active Expired - Lifetime
  • 2002-08-23 JP JP2003523225A patent/JP4351908B2/ja not_active Expired - Fee Related
  • 2002-08-23 AU AU2002313611A patent/AU2002313611A1/en not_active Abandoned
  • 2002-08-23 CZ CZ2004296A patent/CZ2004296A3/cs unknown
  • 2002-08-23 US US10/487,673 patent/US20050029086A1/en not_active Abandoned
  • 2002-08-23 MX MXPA04001793 patent/MX298589B/es active IP Right Grant
  • 2002-08-23 EA EA200400360A patent/EA005831B1/ru not_active IP Right Cessation
  • 2002-08-23 EP EP02753298.5A patent/EP1423361B8/en not_active Expired - Lifetime
  • 2002-08-23 PL PL02370035A patent/PL370035A1/xx not_active IP Right Cessation
  • 2002-08-26 TW TW091119262A patent/TWI311989B/zh not_active IP Right Cessation
  • 2002-08-26 TW TW091119258A patent/TW568793B/zh not_active IP Right Cessation
  • 2002-08-27 MY MYPI20023187A patent/MY144316A/en unknown
  • 2002-08-27 MY MYPI20023186A patent/MY144901A/en unknown
• 2004
  • 2004-02-18 CO CO04013833A patent/CO5560549A2/es not_active Application Discontinuation
  • 2004-03-09 CO CO04021423A patent/CO5560607A2/es not_active Application Discontinuation

Patent Citations (9)

Also Published As

Similar Documents

Legal Events